Thursday, November 19, 2026

Stored, up to 15 year old blood samples lets scientists trace leukaemia back to 5 decades before diagnosis

Good news! Amazing stuff! Cancer is history (soon)!

This research also strongly suggests that individual health baselines periodically taken during the lifetime would help!

"... used blood samples collected annually, some dating back 15 years before diagnosis, as a ‘fossil record’ of the disease's development, tracing it step by step. Using ultra-sensitive DNA sequencing and mathematical modelling, they estimated when each mutation arose and how quickly the affected cells multiplied and competed with other blood cells in the years prior to AML [acute myeloid leukaemia] diagnosis.

AML is an aggressive blood cancer affecting around 2,700 people in the UK each year. Only around one in six survive five years after diagnosis.
Many healthy older people carry blood cells with mutations also found in leukaemia, a condition known as clonal haematopoiesis, but only a small proportion develop AML. What has not been clear is why, because the process has never been tracked year by year in the run-up to diagnosis. ...

This first mutation, acquired before age 20 in two-thirds of the women who developed AML, was followed by decades of slow growth – cells carrying it took years to double in number. Each additional mutation increased their growth rate around two- to three-fold, with cells carrying four cancer-driving mutations doubling in a matter of weeks.

The growth of these groups of cells, known as clones, proved remarkably predictable. Once a clone carrying a cancer-driving mutation was established, it expanded at a steady rate, slowing only when it ran out of room or was overtaken by a faster-growing clone.
In practice, this means a clone's growth rate, measured from a few blood samples today, can be used to estimate how large that clone may become years and even decades into the future.

In at least a third of the AML cases, a clone had come to dominate the blood years before diagnosis, a phenomenon known as a ‘somatic sweep’.
No such sweeps were seen in the women who remained blood cancer-free. The team confirmed the link with AML risk using UK Biobank data, finding that people with these sweeps were at greatly increased risk of developing the disease. ..."

From the abstract:
"Somatic evolution in ageing tissues underlies many cancers1,2. However, our quantitative understanding of the rules governing this pre-cancerous evolution remains incomplete. Here we exploit a unique collection of serial blood samples3, collected annually for up to a decade and beginning as early as 15 years before diagnosis of acute myeloid leukaemia [AML], to provide a quantitative description of pre-cancerous evolutionary dynamics. Using deep duplex sequencing and evolutionary theory, we quantify the acquisition ages and fitness effects of the key driver events in acute myeloid leukaemia development. The first driver mutations are typically acquired in the first few decades of life, when the blood remains highly polyclonal. These early slow-growing clones subsequently acquire multiple further driver mutations that confer selective advantages up to 100-fold larger than the early drivers. These faster-growing clones harbouring multiple driver mutations can cause complete somatic sweeps of the blood decades before diagnosis, a feature strongly associated with future acute myeloid leukaemia. Our data show that the clonal dynamics of blood are consistent with a set of remarkably simple evolutionary rules that strike a balance between chance and determinism."

‘Fossil record’ in stored blood samples lets scientists trace leukaemia back decades before diagnosis | University of Cambridge "Scientists have reconstructed how acute myeloid leukaemia (AML) develops over the decades before diagnosis, showing that in two-thirds of cases the first cancer-driving mutation had been acquired before the age of 20 – more than 50 years before diagnosis. "



Fig. 1: Deep sequencing of serial blood samples in the years preceding AML.


No comments: